IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
Key facts
- Where
- Vandœuvre-lès-Nancy, FranceSee the site
Where in France
- CHRU NancyVandœuvre-lès-Nancy, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Central Hospital, Nancy, France
- Trial code
- NCT03809728
- Record updated
- 7 February 2024
- Original description
Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic biomarkers of natural history and response to biotherapies.Read full original descriptionShow less
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS OF NATURAL HISTORY AND RESPONSE TO BIOTHERAPIES IN INFLAMMATORY BOWEL DISEASE : i-BANK
Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic biomarkers of natural history and response to biotherapies.
Inclusion: Age>=18 years; Patients with an established diagnosis of CD or UC (clinical, biological, radiological, endoscopic or histologic criteria); Patients >=45 kg; Affiliated member of the Social Security system.
Exclusion: Women of childbearing age without a method of contraception; Pregnant women, breastfeeding women; -- Age < 18 years; Persons under the age of 18 years who are deprived of their liberty by decision of a judicial or administrative authority (articles L. 3212-1 and L. 3213-1); Patients with an undetermined colitis; Patients with a non established diagnosis of CD; Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code; Persons under legal protection; Person who does not have the capacity to consent.